|Podcasts|October 14, 2022

The Intricacies of the Pharma Cold Chain

How to navigate the ongoing temperature challenges surrounding storage & distribution

Tom Hart, COO of BioCare, a specialty distributor of medications, discusses the ways to combat the cold chain-warmer temperatures dilemma, along with his future outlook on the industry supply chain as a whole.

The latest episode of The Pharmaceutical Commerce Podcast is available directly on SoundCloud.

Newsletter

Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.

Subscribe Now!

Related Content

Pharma Pulse: Novartis Buys Avidity for $12B, and Trump Threatens 10% Tariff Hike on Canada

ByNicholas Saraceno, Editor

October 28th 2025

Pharma Pulse: Cholesterol Imbalance Tied to Depression Risk, Lilly Acquires Aderum Biotechnologies, and Cambrex Expands API Manufacturing

ByNicholas Saraceno, Editor

October 27th 2025

Pharma Pulse: Alkermes Acquires Avadel in $2.1B Deal, BioNTech Moves to Buy CureVac, and MedTech Industry Embraces Digital-First Models

ByNicholas Saraceno, Editor

October 24th 2025

Pharma Pulse: MJH Life Sciences Expands into Health Systems, Novo Nordisk Board Shakeup Moves Markets, and Mark Cuban Grows Cost Plus Drugs Network

ByNicholas Saraceno, Editor

October 23rd 2025

Pharma Pulse: Telehealth Medication Abortion Requests Surge, FDA Expedites Tzield Review, and New Biopharma Air Network Launches

ByNicholas Saraceno, Editor

October 22nd 2025

The Intricacies of the Pharma Cold Chain

Newsletter

Related Content

Pharma Pulse: Novartis Buys Avidity for $12B, and Trump Threatens 10% Tariff Hike on Canada

Pharma Pulse: Cholesterol Imbalance Tied to Depression Risk, Lilly Acquires Aderum Biotechnologies, and Cambrex Expands API Manufacturing

Pharma Pulse: Alkermes Acquires Avadel in $2.1B Deal, BioNTech Moves to Buy CureVac, and MedTech Industry Embraces Digital-First Models

Pharma Pulse: MJH Life Sciences Expands into Health Systems, Novo Nordisk Board Shakeup Moves Markets, and Mark Cuban Grows Cost Plus Drugs Network

Pharma Pulse: Telehealth Medication Abortion Requests Surge, FDA Expedites Tzield Review, and New Biopharma Air Network Launches

Trending on Pharmaceutical Commerce

Lilly Reveals Plan for New $3 Billion Manufacturing Facility in the Netherlands

One Connection, Endless Impact: Improving Patient Medication Access

Optimizing Your CGT Commercial Distribution Strategy: Four Priorities for a Successful Launch

Reducing HIPAA Breaches